Published in Muscle Nerve on May 01, 1998
Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med (2009) 3.27
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc Natl Acad Sci U S A (2001) 2.26
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis (2008) 2.20
Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve (2009) 2.19
Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci U S A (1999) 1.23
Progressive myopathy and defects in the maintenance of myotendinous junctions in mice that lack talin 1 in skeletal muscle. Development (2008) 1.16
Changes in muscle T2 and tissue damage after downhill running in mdx mice. Muscle Nerve (2011) 1.13
Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice. Muscle Nerve (2010) 1.00
Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses. Am J Pathol (2006) 0.99
Impaired neuromuscular transmission and skeletal muscle fiber necrosis in mice lacking Na/Ca exchanger 3. J Clin Invest (2004) 0.97
Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts. PLoS One (2012) 0.85
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies. Hum Mol Genet (2015) 0.84
Age-related T2 changes in hindlimb muscles of mdx mice. Muscle Nerve (2015) 0.83
The effects of glucocorticoid and voluntary exercise treatment on the development of thoracolumbar kyphosis in dystrophin-deficient mice. PLoS Curr (2012) 0.81
Analysis of skeletal muscle function in the C57BL6/SV129 syncoilin knockout mouse. Mamm Genome (2008) 0.80
Exercise-induced alterations and loss of sarcomeric M-line organization in the diaphragm muscle of obscurin knockout mice. Am J Physiol Cell Physiol (2016) 0.78
Altered ROS production, NF-κB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cells. Biochim Biophys Acta (2015) 0.78
Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice. Hum Mol Genet (2015) 0.77
Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients. J Neuromuscul Dis (2015) 0.77
Functional performance and muscle strength phenotypes in men and women with Danon disease. Muscle Nerve (2010) 0.76
The Effects of Experimental Sleep Apnea on Cardiac and Respiratory Functions in 6 and 18 Month Old Dystrophic (mdx) Mice. PLoS One (2016) 0.75
Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture. Nutrients (2016) 0.75
A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations. Br J Cancer (2006) 4.46
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med (2001) 3.17
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06
Overproduction of three genes leads to camphor resistance and chromosome condensation in Escherichia coli. Genetics (1996) 1.64
Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol (1992) 1.60
Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord (1997) 1.43
Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia (2006) 1.35
Endobronchial ultrasonography with guide-sheath for peripheral pulmonary lesions. Eur Respir J (2004) 1.35
Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr (2001) 1.32
Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve (1994) 1.28
Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve (1992) 1.23
High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest (1994) 1.22
Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol (1997) 1.22
Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther (2001) 1.17
In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res (2000) 1.16
Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res (1998) 1.16
Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience (2006) 1.13
Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc (1992) 1.11
FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum Gene Ther (1995) 1.11
Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther (2007) 1.08
Meganucleases can restore the reading frame of a mutated dystrophin. Gene Ther (2010) 1.07
Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts. Muscle Nerve (1991) 1.05
Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve (1994) 1.03
Non-uniform release at the frog neuromuscular junction: evidence of morphological and physiological plasticity. Brain Res (1987) 1.03
Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant (1997) 1.02
Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol (1999) 1.01
Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome. Br J Cancer (1999) 1.00
Progress in myoblast transplantation: a potential treatment of dystrophies. Microsc Res Tech (2000) 0.99
N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers. Br J Cancer (2002) 0.97
Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways. Am J Transplant (2007) 0.95
Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol (1995) 0.95
Tumor necrosis factor-alpha (TNF-alpha) stimulates chemotactic response in mouse myogenic cells. Cell Transplant (2003) 0.95
Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res (2006) 0.94
Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer. Cancer (1995) 0.93
Functional EGFP-dystrophin fusion proteins for gene therapy vector development. Protein Eng (2000) 0.93
Myoblast transplantation in whole muscle of nonhuman primates. J Neuropathol Exp Neurol (2000) 0.92
Expression of major histocompatibility complex antigens on human myoblasts. Transplant Proc (1991) 0.92
Myoblast transplantation in monkeys: control of immune response by FK506. J Neuropathol Exp Neurol (1996) 0.91
Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles. Biochem Biophys Res Commun (1998) 0.91
A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success. Am J Transplant (2007) 0.90
Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer (1997) 0.90
Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible. Transplant Proc (1993) 0.90
Transfection of large plasmids in primary human myoblasts. Gene Ther (2001) 0.90
[Surgical experience of three cases of lung cancer with polypoid-type left atrial infiltration--focus on the combined resection of the left atrium using cardiopulmonary bypass]. Nihon Kyobu Geka Gakkai Zasshi (1985) 0.89
Non-uniform responses to Ca2+ along the frog neuromuscular junction: effects on the probability of spontaneous and evoked transmitter release. Neuroscience (1991) 0.89
DNA sequence from a fossil pollen of Abies spp. from Pleistocene peat. Genes Genet Syst (1996) 0.89
Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther (2001) 0.89
Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp Neurol (1999) 0.88
Immune reactions after myoblast transplantation in mouse muscles. Transplant Proc (1992) 0.88
Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy. Clin Sci (Lond) (1991) 0.88
Pure akinesia: an atypical manifestation of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (1991) 0.88
Diabetes mellitus and the sensory neuron. J Neuropathol Exp Neurol (2004) 0.88
Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice. Cell Transplant (1994) 0.88
Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success. Biochem Cell Biol (2003) 0.87
Does small-dose gamma-ray radiation induce endogenous antioxidant potential in vivo? Biol Pharm Bull (1997) 0.87
Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer. Cancer Res (1995) 0.87
Depression and frequency facilitation at a synapse in Aplysia californica: evidence for regulation by availability of transmitter. Brain Res (1974) 0.87
Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. J Histochem Cytochem (1993) 0.86
Experimental infection with Mycoplasma pneumoniae in the young hamster: location of ferritin-labeled antibody binding to infective tissue. Tohoku J Exp Med (1974) 0.86
Pulmonary sclerosing hemangioma of the lung. A type II pneumocytoma by immunohistochemical and immunoelectron microscopic studies. Cancer (1989) 0.86
Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice. Cell Transplant (2009) 0.86
[The influence of smoking on the development of various subtypes of pulmonary carcinoma]. Gan No Rinsho (1987) 0.86
Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant (1999) 0.86
Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM. Eur J Histochem (1993) 0.86
Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Hum Gene Ther (1996) 0.86
Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant. Br J Cancer (2008) 0.85
Non-uniform distribution of miniature endplate potential amplitudes along the length of the frog neuromuscular junction. Neurosci Lett (1987) 0.85
Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin prduced only a relatively small increase of dystrophin-positive membrane. Muscle Nerve (1998) 0.85
Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases. Cell Transplant (2001) 0.85
Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase. Gene Ther (2006) 0.85
Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation (1995) 0.84
Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells. Br J Cancer (2008) 0.84
Frequency facilitation and post-tetanic potentiation of a unitary synaptic potential in Aplysia californica are limited by different processes. Brain Res (1976) 0.84
Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice. Neuromuscul Disord (2002) 0.84
Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve (1995) 0.84
Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice. Muscle Nerve (1995) 0.84
Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history. Am J Clin Pathol (1994) 0.83
Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis. Neurology (1989) 0.83
Resistance to ischemic conduction block of the peripheral nerve in hyperglycemic rats: an electrophysiological study. Muscle Nerve (1988) 0.82
Scale-up of a myoblast culture process. J Biotechnol (2001) 0.82
Identification of homozygous and heterozygous dy2J mice by PCR. Neuromuscul Disord (2000) 0.82
Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve (1995) 0.82
[Intrapulmonary metastasis in resected cases of pulmonary carcinoma]. Nihon Kyobu Geka Gakkai Zasshi (1983) 0.82
Telomerase allows the immortalization of T antigen-positive DMD myoblasts: a new source of cells for gene transfer application. Gene Ther (2000) 0.82
Surgical treatment of pulmonary metastases from uterine cervical cancer. Operation method by lung tumor size. J Thorac Cardiovasc Surg (1992) 0.82